Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2005 Oct 24;6(3):E504–E512. doi: 10.1208/pt060363

Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels

Bharathi Devarakonda 1, Ning Li 1, Melgardt M de Villiers 2,✉
PMCID: PMC2750397  PMID: 16354011

Abstract

The objective of this study was to determine the effect of ethylenediamine core PAMAM dendrimers, on the release of nifedipine suspended in aqueous gels and to correlate release to the increase in solubility afforded by the dendrimers. Drug release from aqueous 5% HPMC gels containing nifedipine (2% wt/vol) through 0.2-μm membranes was measured using Enhancer cells and 50% ethanolic solution as the receptor medium. The release from gels containing PAMAM G-3 and G-5 (0.25%–1% wt/vol) was compared with gels containing the cosolvent isopropyl alcohol (10%–80% vol/vol). PAMAM dendrimers significantly increased the solubility of nifedipine. This caused a significant increase in the release rate of nifedipine from the gel suspensions. The increase in drug release depended on the concentration and generation size of the dendrimers added. For higher generations (G-5) lower concentrations were needed to obtain equivalent increases in release. Although the increase in solubility and release was not as high as from gels containing high concentrations of the cosolvent isopropyl alcohol, the dendrimers prevented the recrystallization of the drug that was observed when the gels containing isopropyl alcohol were left open.

Keywords: PAMAM dendrimers, Nifedipine, Release, Gel

Full Text

The Full Text of this article is available as a PDF (554.5 KB).

References

  • 1.Ali SL. Nifedipine. In: Florey K, editor. Analytical Profiles of Drug Substances. New York, NY: Academic Press; 1989. pp. 223–228. [Google Scholar]
  • 2.Perrotti P, Antropoli C, Molino D, Stefano G, Antropoli M. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Col Rec. 2001;44:405–409. doi: 10.1007/BF02234741. [DOI] [PubMed] [Google Scholar]
  • 3.Ezri T, Susmallian S. Topical nifedipine vs topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Col Rec. 2003;46:805–808. doi: 10.1007/s10350-004-6660-8. [DOI] [PubMed] [Google Scholar]
  • 4.Israel A. Topical gel for the treatment of refractory leg ulcer. Int J Pharm Comp. 2003;7:176–178. [PubMed] [Google Scholar]
  • 5.Merenstein D, Rosenbaum D. Is topical nifedipine effective for chronic anal fissures? J Fam Prac. 2003;52:190–192. [PubMed] [Google Scholar]
  • 6.Slawson D. Topical nifedipine plus lidocaine gel effective for anal fissures. Am Fam Physiol. 2003;67:1781–1781. [Google Scholar]
  • 7.Segarra J, Santafe J, Garrido M, Martinez de Ibarreta MJ. The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits. Gen Pharmacol. 1993;24:1163–1171. doi: 10.1016/0306-3623(93)90364-4. [DOI] [PubMed] [Google Scholar]
  • 8.Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement. J AIChE. 1975;21:985–996. doi: 10.1002/aic.690210522. [DOI] [Google Scholar]
  • 9.Kondo S, Mizuno T, Sugimoto I. Effects of penetration enhancers on percutaneous absorption of nifedipine. Comparison between DDET and Azone. J Pharmacobiodyn. 1988;11:88–95. doi: 10.1248/bpb1978.11.88. [DOI] [PubMed] [Google Scholar]
  • 10.Chauhan AS, Sridevi S, Chalasani KB, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Cont Rel. 2003;90:335–343. doi: 10.1016/S0168-3659(03)00200-1. [DOI] [PubMed] [Google Scholar]
  • 11.El-Sayed M, Kiani MF, Naimark MD, Hikal AH, Gandhehari H. Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm Res. 2001;18:23–28. doi: 10.1023/A:1011066408283. [DOI] [PubMed] [Google Scholar]
  • 12.El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers. J Cont Rel. 2002;8:355–365. doi: 10.1016/S0168-3659(02)00087-1. [DOI] [PubMed] [Google Scholar]
  • 13.Kolhe P, Misra E, Kannan RM, Kanna S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm. 2003;259:143–160. doi: 10.1016/S0378-5173(03)00225-4. [DOI] [PubMed] [Google Scholar]
  • 14.Wang Z, Itoh Y, Hosaka Y, et al. Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. J. Biosci Bioeng. 2003;95:541–543. doi: 10.1016/s1389-1723(03)80059-2. [DOI] [PubMed] [Google Scholar]
  • 15.Purohit G, Sakthivel T, Florence AT. The interaction of cationic dendrons with albumin and their diffusion through cellulose membranes. Int J Pharm. 2003;254:37–41. doi: 10.1016/S0378-5173(02)00679-8. [DOI] [PubMed] [Google Scholar]
  • 16.Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine and tropicamide. J Cont Rel. 2005;102:23–38. doi: 10.1016/j.jconrel.2004.09.015. [DOI] [PubMed] [Google Scholar]
  • 17.Boje KM, Sak M, Fung HL. Complexation of nifedipine with substituted phenolic ligands. Pharm Res. 1988;5:655–659. doi: 10.1023/A:1015979021590. [DOI] [PubMed] [Google Scholar]
  • 18.Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solid-state characterization of nifedipine solid dispersions. Int J Pharm. 2002;236:111–123. doi: 10.1016/S0378-5173(02)00019-4. [DOI] [PubMed] [Google Scholar]
  • 19.Devarakonda B, Hill RA, Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm. 2004;284:133–140. doi: 10.1016/j.ijpharm.2004.07.006. [DOI] [PubMed] [Google Scholar]
  • 20.Higuchi T, Conners KA. Phase-solubility techniques. In: Reilly CN, editor. Advances in analytical chemistry and instrumentation. New York: John Wiley; 1965. pp. 117–212. [Google Scholar]
  • 21.Jain NK, Patel VV, Taneja LN. Hydrotropic solubilation of nifedipine. Pharmazie. 1988;43(3):194–196. [PubMed] [Google Scholar]
  • 22.Loftsson T, Fridriksdottir H, Olafsdottir B, Gudmundson O. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm Nord. 1991;3:215–217. [Google Scholar]
  • 23.Larrucea E, Arellano A, Santoyo S, Ygartua P. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug. Drug Dev Ind Pharm. 2001;27:251–260. doi: 10.1081/DDC-100000243. [DOI] [PubMed] [Google Scholar]
  • 24.Esfand R, Tomalia DA. Dendrimers and other dendritic polymers. New York: John Wiley; 2001. pp. 589–604. [Google Scholar]
  • 25.Campbell PS, Chandrasekaran SKUS. Dosage for administrating and percutaneous absorption enhancer. US patent 4379454. April 13, 1983.
  • 26.Berner B, Mazzenga GC, Otter JH, Steffens RJ, Juang RH, Ebert CD. Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J Pharm Sci. 1989;78:402–407. doi: 10.1002/jps.2600780512. [DOI] [PubMed] [Google Scholar]
  • 27.Caira MR, Robbertse Y, Bergh JJ, Song M, Villiers MM. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine. J Pharm Sci. 2003;92:2519–2533. doi: 10.1002/jps.10506. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES